T-cell costimulatory molecules: Optimal targets for the treatment of allergic airway disease with monoclonal antibodies

Journal of Allergy and Clinical Immunology

Volumn 116, Issue 4, 2005, Pages 906-909

  Kroczek, Richard ^a   Hamelmann, Eckard ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allergic airway disease; Costimulatory molecules; Depletion therapy; Inducible costimulator; Monoclonal antibodies; OX40; T cells

Indexed keywords

ANTIINFECTIVE AGENT; CD134 ANTIGEN; CD137 ANTIGEN; CD27 ANTIGEN; CD28 ANTIGEN; CD30 ANTIGEN; CD40 LIGAND; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN;

ALLERGIC ASTHMA; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; BRONCHUS HYPERREACTIVITY; CHRONIC DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOPATHOGENESIS; MEMORY CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD137; ANTIGENS, CD30; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; ASTHMA; CD40 LIGAND; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 25844456563     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.07.005     Document Type: Review

References (17)

1. E. Hamelmann, and R.P. Schleimer Corticosteroid treatment in bronchial asthma: for better or for worse? J Allergy Clin Immunol 111 2003 248 250
2. L.P. Ngoc, D.R. Gold, A.O. Tzianabos, S.T. Weiss, and J.C. Celedon Cytokines, allergy, and asthma Curr Opin Allergy Clin Immunol 5 2005 161 166
3. U. Wahn, and E. Hamelmann Anti-IgE therapy Clin Allergy Immunol 18 2004 625 640
4. S. Holgate, T. Casale, S. Wenzel, J. Bousquet, Y. Deniz, and C. Reisner The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation J Allergy Clin Immunol 115 2005 459 465
5. A.H. Sharpe, and G.J. Freeman The B7-CD28 superfamily Nat Rev Immunol 2 2002 116 126
6. R.A. Kroczek, H.W. Mages, and A. Hutloff Emerging paradigms of T-cell co-stimulation Curr Opin Immunol 16 2004 321 327
7. M.J. Leckie Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models Am J Respir Med 2 2003 245 259
8. T. Kawai, D. Andrews, R.B. Colvin, D.H. Sachs, and A.B. Cosimi Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand Nat Med 6 2000 114
9. A. Veillette, and S. Latour The SLAM family of immune-cell receptors Curr Opin Immunol 15 2003 277 285
10. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10 J Exp Med 197 2003 181 193
11. K.C. Beier, A. Hutloff, M. Löhning, T. Kallinich, R.A. Kroczek, and E. Hamelmann Inducible costimulator-positive T cells are required for allergen-induced local B-cell infiltration and antigen-specific IgE production in lung tissue J Allergy Clin Immunol 114 2004 775 782
12. M. Tarkowski Expression and a role of CD30 in regulation of T-cell activity Curr Opin Hematol 10 2003 267 271
13. M. Croft Costimulation of T cells by OX40, 4-1BB, and CD27 Cytokine Growth Factor Rev 14 2003 265 273
14. P. Lane Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells J Exp Med 191 2000 201 206
15. B. Grimbacher, A. Hutloff, M. Schlesier, E. Glocker, K. Warnatz, and R. Dräger Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency Nat Immunol 4 2003 261 268
16. - accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells Immunity 18 2003 643 654
17. T. Kallinich, K.C. Beier, E.W. Gelfand, R.A. Kroczek, and E. Hamelmann Co-Stimulatory Molecules as potential targets for therapeutic intervention in allergic airway disease Clin Exp Allergy 2005 In press